<DOC>
	<DOCNO>NCT02659358</DOCNO>
	<brief_summary>The purpose study evaluate association wearable biosensor data , performance status patient-reported outcome cancer patient . Participants study wear biosensor ( Fitbit Charge HR® ) 15 day respond questionnaires assess patient report outcome measure include physical function , emotional distress , pain interference , sleep disturbance fatigue . Eligible patient diagnosis advance cancer . Patients must great 18 year age English speaking due questionnaire administer study . Patients must also ambulatory ( use walk aid , cane rollator , acceptable ) access smartphone internet access ( IOS Android ) . It also necessary patient schedule oncology clinic visit least every 2 week .</brief_summary>
	<brief_title>Evaluating Use Wearable Biosensors PROs Assess Performance Status Patients With Cancer</brief_title>
	<detailed_description>This study aim measure association biosensor data , performance status patient-reported outcome . This study also evaluate feasibility use Fitbit activity monitor cancer population capture objective activity data . The study recruit patient advanced cancer diagnosis ( stage 3 4 ) refer treat oncologist . This exploratory study follow patient stage 3-4 cancer period 15 day . Subjects provide Fitbt Charge HR® activity monitor . They request wear Fitbit Charge HR® time , except bath perform activity activity monitor become submerged water . Subjects ask wear Fitbit Charge HR® two week . They see clinic baseline , end week 1 ( day 8 ) end 2 week ( day 15 ) physical exam , evaluation performance status treat oncologist practice nurse use standardized scale administration PROMIS® questionnaire . Patients follow 6 month last clinic visit adverse event , hospitalization survival . Thirty subject enrol study .</detailed_description>
	<criteria>Diagnosis advance solid malignancy ( Stage 3 4 ) measurable disease , follow oncologist 18 year old English speaking Ambulatory ( use walk aid , cane rollator , acceptable ) Access IOS Android smartphone internet access Expected oncology clinic visit least every 2 week Have understanding , ability , willingness fully comply study procedure restriction Ability consent Allergy surgical steel elastomer/rubber Using pacemaker , implantable cardiac defibrillator , neurostimulator , hear aid , cochlear implant , electronic medical equipment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Advanced solid malignancy</keyword>
	<keyword>Activity monitor</keyword>
	<keyword>Biosensor</keyword>
	<keyword>Fitbit</keyword>
	<keyword>Patient Reported Outcomes ( PRO )</keyword>
	<keyword>Stage 3/4 cancer</keyword>
	<keyword>Performance Status</keyword>
	<keyword>Eastern Cooperative Oncology Group Performance Status ( ECOG-PS )</keyword>
</DOC>